×
S&P 500   3,977.31 (+0.91%)
DOW   32,116.71 (+0.59%)
QQQ   291.37 (+1.44%)
AAPL   140.69 (+0.24%)
MSFT   262.54 (+1.12%)
FB   183.64 (+1.30%)
GOOGL   2,115.17 (-0.20%)
AMZN   2,136.96 (+2.64%)
TSLA   661.05 (+5.24%)
NVDA   168.64 (+4.40%)
BABA   82.29 (-0.22%)
NIO   14.64 (+0.07%)
AMD   92.92 (+1.93%)
CGC   5.04 (+5.88%)
MU   68.05 (+2.15%)
T   21.28 (+0.57%)
GE   74.24 (-0.38%)
F   12.73 (+2.50%)
DIS   103.30 (+1.68%)
AMC   11.69 (+12.51%)
PFE   53.81 (+0.75%)
PYPL   79.91 (+1.60%)
NFLX   187.11 (+3.75%)
S&P 500   3,977.31 (+0.91%)
DOW   32,116.71 (+0.59%)
QQQ   291.37 (+1.44%)
AAPL   140.69 (+0.24%)
MSFT   262.54 (+1.12%)
FB   183.64 (+1.30%)
GOOGL   2,115.17 (-0.20%)
AMZN   2,136.96 (+2.64%)
TSLA   661.05 (+5.24%)
NVDA   168.64 (+4.40%)
BABA   82.29 (-0.22%)
NIO   14.64 (+0.07%)
AMD   92.92 (+1.93%)
CGC   5.04 (+5.88%)
MU   68.05 (+2.15%)
T   21.28 (+0.57%)
GE   74.24 (-0.38%)
F   12.73 (+2.50%)
DIS   103.30 (+1.68%)
AMC   11.69 (+12.51%)
PFE   53.81 (+0.75%)
PYPL   79.91 (+1.60%)
NFLX   187.11 (+3.75%)
S&P 500   3,977.31 (+0.91%)
DOW   32,116.71 (+0.59%)
QQQ   291.37 (+1.44%)
AAPL   140.69 (+0.24%)
MSFT   262.54 (+1.12%)
FB   183.64 (+1.30%)
GOOGL   2,115.17 (-0.20%)
AMZN   2,136.96 (+2.64%)
TSLA   661.05 (+5.24%)
NVDA   168.64 (+4.40%)
BABA   82.29 (-0.22%)
NIO   14.64 (+0.07%)
AMD   92.92 (+1.93%)
CGC   5.04 (+5.88%)
MU   68.05 (+2.15%)
T   21.28 (+0.57%)
GE   74.24 (-0.38%)
F   12.73 (+2.50%)
DIS   103.30 (+1.68%)
AMC   11.69 (+12.51%)
PFE   53.81 (+0.75%)
PYPL   79.91 (+1.60%)
NFLX   187.11 (+3.75%)
S&P 500   3,977.31 (+0.91%)
DOW   32,116.71 (+0.59%)
QQQ   291.37 (+1.44%)
AAPL   140.69 (+0.24%)
MSFT   262.54 (+1.12%)
FB   183.64 (+1.30%)
GOOGL   2,115.17 (-0.20%)
AMZN   2,136.96 (+2.64%)
TSLA   661.05 (+5.24%)
NVDA   168.64 (+4.40%)
BABA   82.29 (-0.22%)
NIO   14.64 (+0.07%)
AMD   92.92 (+1.93%)
CGC   5.04 (+5.88%)
MU   68.05 (+2.15%)
T   21.28 (+0.57%)
GE   74.24 (-0.38%)
F   12.73 (+2.50%)
DIS   103.30 (+1.68%)
AMC   11.69 (+12.51%)
PFE   53.81 (+0.75%)
PYPL   79.91 (+1.60%)
NFLX   187.11 (+3.75%)
NASDAQ:AXON

Axon Enterprise (AXON) Stock Forecast, Price & News

$95.46
+2.90 (+3.13%)
(As of 05/25/2022 03:46 PM ET)
Add
Compare
Today's Range
$91.32
$95.82
50-Day Range
$84.37
$140.00
52-Week Range
$82.49
$209.00
Volume
6,430 shs
Average Volume
474,041 shs
Market Capitalization
$6.78 billion
P/E Ratio
183.58
Dividend Yield
N/A
Beta
0.55
30 days | 90 days | 365 days | Advanced Chart
Receive AXON News and Ratings via Email

Sign-up to receive the latest news and ratings for Axon Enterprise and its competitors with MarketBeat's FREE daily newsletter.

Axon Enterprise logo

About Axon Enterprise

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include TASER 7, TASER X26P, TASER X2, TASER Consumer devices, and related cartridges; on-officer body cameras, Axon Fleet in-car systems, and other devices; Axon Evidence digital evidence management software; Axon Signal enabled devices, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. It sells its products through its direct sales force, distribution partners, online store, and third-party resellers. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Ordnance & accessories, except vehicles & guided missiles
Sub-Industry
Systems Software
Current Symbol
NASDAQ:AXON
Employees
2,992
Year Founded
N/A

Sales & Book Value

Annual Sales
$863.38 million
Book Value
$15.84 per share

Profitability

Net Income
$-60.02 million
Pretax Margin
-2.08%

Debt

Price-To-Earnings

Miscellaneous

Free Float
66,111,000
Market Cap
$6.78 billion
Optionable
Optionable

Company Calendar

Last Earnings
5/10/2022
Today
5/25/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.28 out of 5 stars

Industrial Products Sector

107th out of 257 stocks

Ordnance & Accessories, Except Vehicles & Guided Missiles Industry

3rd out of 8 stocks

Analyst Opinion: 4.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.0 5 -4 -3 -2 -1 -













Axon Enterprise (NASDAQ:AXON) Frequently Asked Questions

Is Axon Enterprise a buy right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axon Enterprise in the last twelve months. There are currently 1 hold rating, 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Axon Enterprise stock.
View analyst ratings for Axon Enterprise
or view top-rated stocks.

When is Axon Enterprise's next earnings date?

Axon Enterprise is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Axon Enterprise
.

How were Axon Enterprise's earnings last quarter?

Axon Enterprise, Inc. (NASDAQ:AXON) announced its quarterly earnings results on Tuesday, May, 10th. The biotechnology company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.16. The biotechnology company had revenue of $256.43 million for the quarter, compared to the consensus estimate of $233.57 million. Axon Enterprise had a net margin of 4.62% and a trailing twelve-month return on equity of 3.90%. The firm's quarterly revenue was up 31.5% on a year-over-year basis. During the same period last year, the firm posted ($0.75) EPS.
View Axon Enterprise's earnings history
.

What guidance has Axon Enterprise issued on next quarter's earnings?

Axon Enterprise issued an update on its FY 2022 earnings guidance on Monday, May, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.05 billion-$1.10 billion, compared to the consensus revenue estimate of $1.05 billion.

What price target have analysts set for AXON?

9 brokers have issued 1 year price targets for Axon Enterprise's shares. Their forecasts range from $120.00 to $232.00. On average, they expect Axon Enterprise's stock price to reach $172.89 in the next twelve months. This suggests a possible upside of 81.1% from the stock's current price.
View analysts' price targets for Axon Enterprise
or view top-rated stocks among Wall Street analysts.

Who are Axon Enterprise's key executives?
Axon Enterprise's management team includes the following people:
Who are some of Axon Enterprise's key competitors?
What other stocks do shareholders of Axon Enterprise own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axon Enterprise investors own include Novavax (NVAX), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), (CGC), Micron Technology (MU), TherapeuticsMD (TXMD), ACADIA Pharmaceuticals (ACAD), bluebird bio (BLUE) and Arena Pharmaceuticals (ARNA).

When did Axon Enterprise IPO?

(AXON) raised $251 million in an initial public offering (IPO) on Thursday, June 11th 2015. The company issued 17,900,000 shares at a price of $13.00-$15.00 per share. Jefferies, Evercore ISI and RBC Capital Markets acted as the underwriters for the IPO and JMP Securities and Baird were co-managers.

What is Axon Enterprise's stock symbol?

Axon Enterprise trades on the NASDAQ under the ticker symbol "AXON."

Who are Axon Enterprise's major shareholders?

Axon Enterprise's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (10.73%), Vanguard Group Inc. (8.42%), Baillie Gifford & Co. (5.80%), Capital International Investors (3.75%), State Street Corp (3.13%) and William Blair Investment Management LLC (2.46%). Company insiders that own Axon Enterprise stock include Adriane M Brown, Caitlin Elizabeth Kalinowski, Hadi Partovi, Jawad A Ahsan, Jeffrey C Kunins, Joshua Isner, Julie A Cullivan, Luke Larson, Matthew R Mcbrady, Matthew R Mcbrady and Patrick W Smith.
View institutional ownership trends for Axon Enterprise
.

Which major investors are selling Axon Enterprise stock?

AXON stock was sold by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, Baillie Gifford & Co., First Trust Advisors LP, Wellington Management Group LLP, Victory Capital Management Inc., TimesSquare Capital Management LLC, William Blair Investment Management LLC, and Federated Hermes Inc.. Company insiders that have sold Axon Enterprise company stock in the last year include Jawad A Ahsan, Jeffrey C Kunins, Joshua Isner, Julie A Cullivan, Luke Larson, Matthew R Mcbrady, and Patrick W Smith.
View insider buying and selling activity for Axon Enterprise
or view top insider-selling stocks.

Which major investors are buying Axon Enterprise stock?

AXON stock was bought by a variety of institutional investors in the last quarter, including Capital International Investors, State Street Corp, BlackRock Inc., Capital Group International Inc. CA , Blair William & Co. IL, J. Goldman & Co LP, Zevenbergen Capital Investments LLC, and Vaughan Nelson Investment Management L.P.. Company insiders that have bought Axon Enterprise stock in the last two years include Adriane M Brown, Caitlin Elizabeth Kalinowski, and Hadi Partovi.
View insider buying and selling activity for Axon Enterprise
or or view top insider-buying stocks.

How do I buy shares of Axon Enterprise?

Shares of AXON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Axon Enterprise's stock price today?

One share of AXON stock can currently be purchased for approximately $95.46.

How much money does Axon Enterprise make?

Axon Enterprise has a market capitalization of $6.78 billion and generates $863.38 million in revenue each year. The biotechnology company earns $-60.02 million in net income (profit) each year or $0.519990 on an earnings per share basis.

How many employees does Axon Enterprise have?

Axon Enterprise employs 2,992 workers across the globe.

What is Axon Enterprise's official website?

The official website for Axon Enterprise is www.axovant.com.

How can I contact Axon Enterprise?

Axon Enterprise's mailing address is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. The biotechnology company can be reached via phone at (480) 991-0797, via email at [email protected], or via fax at 480-991-0791.

This page was last updated on 5/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.